Click the steps on the interactive journey below to learn more.*
The words no one wants to hear: “You have cancer.” It can be an emotional time. Fortunately, multiple myeloma is a treatable cancer, and improvements in survival have been made over the past 10 years. Once you’re diagnosed as having multiple myeloma, you’ll be referred to a specialist, either a hematologist or an oncologist, who will consider your treatment options.
There are several treatment options, including injectable and oral medicines, chemotherapy, and stem cell transplants. Your doctor will discuss your treatment options with you and the associated risks and benefits of each.
When treatment begins, it’s important to follow the advice of your doctors and nurses. Take your medicines as prescribed and for as long as they are prescribed. Ask questions when you don’t understand something, and try to stay organized with your treatment and appointments.
You may experience side effects while on treatment. Some of these side effects may be serious. If you have certain side effects, your doctor may adjust your treatment dose. Your doctor may also delay or stop treatment. Make sure to always discuss symptoms and side effects with your healthcare team.
When treatment helps manage your multiple myeloma and symptoms improve, doctors refer to this as a response. There are varying degrees of response, but millions of myeloma cells can still remain in your body, even with a complete response. The objective of treatment is to keep multiple myeloma controlled for as long as possible.
Myeloma cells that survive treatment can continue to multiply. This can lead to a relapse, meaning the disease returns. Make sure you tell your doctor about how you feel and any changes you’re experiencing. Your doctor will review your options, the risks and benefits, and help you create a treatment plan.
Relapse is common but treatable. When a relapse occurs, ask your doctor about oral POMALYST® (pomalidomide) with convenient, once-daily dosing.†
†POMALYST is taken in combination with dexamethasone on days 1-21 of a 28-day cycle.
POMALYST is a prescription medicine, taken along with the medicine dexamethasone, used to treat people with multiple myeloma who have previously received at least 2 medicines to treat multiple myeloma, including a proteasome inhibitor and lenalidomide, and whose disease has become worse during treatment or within 60 days of finishing the last treatment. It is not known if POMALYST is safe and effective in children. POMALYST is only available through a restricted distribution program, POMALYST REMS®. Please see Important Safety Information for POMALYST below and full Prescribing Information, including Boxed WARNINGS and Medication Guide.
Your doctor may have told you that your multiple myeloma has come back, also known as a relapse. This means your multiple myeloma is no longer responding to the medications you’re taking. At this point, your doctor may switch your treatment to POMALYST—another oral IMiD therapy that's proven to help you fight disease progression after relapse. POMALYST is a pill that offers convenient, once-daily dosing.‡
WARNINGS: Risk to unborn babies, and blood clots.
Before you begin taking POMALYST, you must read and agree to all of the instructions in the POMALYST REMS® program. Before prescribing POMALYST, your healthcare provider (HCP) will explain the POMALYST REMS program to you and have you sign the Patient-Physician Agreement Form.
POMALYST can cause serious side effects, including:
Call your healthcare provider or get medical help right away if you get any of the following during treatment with POMALYST:
Get emergency medical help right away if you develop any of the following signs or symptoms during treatment with POMALYST:
Do not take POMALYST if you:
Take POMALYST exactly as prescribed and follow all the instructions of the POMALYST REMS program.